Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Antiretroviral drugs in severe acute respiratory syndrome].

Identifieur interne : 003C26 ( Main/Exploration ); précédent : 003C25; suivant : 003C27

[Antiretroviral drugs in severe acute respiratory syndrome].

Auteurs : Yazdan Yazdanpanah ; Benoît Guéry

Source :

RBID : pubmed:16462674

Descripteurs français

English descriptors

Abstract

Inhibition of viral assembly (protease inhibitors) and of fusion of viral and target membranes (fusion inhibitors) are general approaches to antiviral treatment, not specific for HIV. Nonetheless, the agents that induce these phenomena are most often specific for a given virus or virus family. Drugs developed for HIV treatment were reevaluated for use against severe acute respiratory syndrome-coronavirus (SARS-CoV) during and after the epidemic in 2003, in view of the absence of any other available treatment. Of the protease and entry inhibitors approved for treating HIV-infected patients, none was effective against SARS-CoV, although in vitro activity against this virus was reported for the protease inhibitor lopinavir/ritonavir, in results that have not been confirmed in the most recent studies. The epidemiologic methods used to assess this drug's efficacy are not robust. Preliminary results for SARS treatment with protease and entry inhibitors, although at early stages of development, are promising.

DOI: 10.1016/s0755-4982(06)74531-6
PubMed: 16462674


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Antiretroviral drugs in severe acute respiratory syndrome].</title>
<author>
<name sortKey="Yazdanpanah, Yazdan" sort="Yazdanpanah, Yazdan" uniqKey="Yazdanpanah Y" first="Yazdan" last="Yazdanpanah">Yazdan Yazdanpanah</name>
<affiliation>
<nlm:affiliation>Service universitaire des maladies infectieuses et du voyageur, Centre Hospitalier de Tourcoing, Faculté de Médecine de Lille. yyazdan@yahoo.com</nlm:affiliation>
<wicri:noCountry code="subField">Faculté de Médecine de Lille</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Guery, Benoit" sort="Guery, Benoit" uniqKey="Guery B" first="Benoît" last="Guéry">Benoît Guéry</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16462674</idno>
<idno type="pmid">16462674</idno>
<idno type="doi">10.1016/s0755-4982(06)74531-6</idno>
<idno type="wicri:Area/PubMed/Corpus">002353</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002353</idno>
<idno type="wicri:Area/PubMed/Curation">002353</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002353</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001F16</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001F16</idno>
<idno type="wicri:Area/Ncbi/Merge">001369</idno>
<idno type="wicri:Area/Ncbi/Curation">001369</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001369</idno>
<idno type="wicri:doubleKey">0755-4982:2006:Yazdanpanah Y:antiretroviral:drugs:in</idno>
<idno type="wicri:Area/Main/Merge">003D84</idno>
<idno type="wicri:Area/Main/Curation">003C26</idno>
<idno type="wicri:Area/Main/Exploration">003C26</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Antiretroviral drugs in severe acute respiratory syndrome].</title>
<author>
<name sortKey="Yazdanpanah, Yazdan" sort="Yazdanpanah, Yazdan" uniqKey="Yazdanpanah Y" first="Yazdan" last="Yazdanpanah">Yazdan Yazdanpanah</name>
<affiliation>
<nlm:affiliation>Service universitaire des maladies infectieuses et du voyageur, Centre Hospitalier de Tourcoing, Faculté de Médecine de Lille. yyazdan@yahoo.com</nlm:affiliation>
<wicri:noCountry code="subField">Faculté de Médecine de Lille</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Guery, Benoit" sort="Guery, Benoit" uniqKey="Guery B" first="Benoît" last="Guéry">Benoît Guéry</name>
</author>
</analytic>
<series>
<title level="j">Presse medicale (Paris, France : 1983)</title>
<idno type="ISSN">0755-4982</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anti-HIV Agents (therapeutic use)</term>
<term>Anti-Retroviral Agents (administration & dosage)</term>
<term>Anti-Retroviral Agents (therapeutic use)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Clinical Trials as Topic</term>
<term>Cohort Studies</term>
<term>Drug Therapy, Combination</term>
<term>HIV Infections (drug therapy)</term>
<term>Humans</term>
<term>Lopinavir</term>
<term>Protease Inhibitors (administration & dosage)</term>
<term>Protease Inhibitors (pharmacology)</term>
<term>Protease Inhibitors (therapeutic use)</term>
<term>Pyrimidinones (administration & dosage)</term>
<term>Pyrimidinones (pharmacology)</term>
<term>Pyrimidinones (therapeutic use)</term>
<term>Ribavirin (administration & dosage)</term>
<term>Ribavirin (therapeutic use)</term>
<term>Ritonavir (administration & dosage)</term>
<term>Ritonavir (pharmacology)</term>
<term>Ritonavir (therapeutic use)</term>
<term>SARS Virus (drug effects)</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Viral Fusion Proteins (antagonists & inhibitors)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Agents antiVIH (usage thérapeutique)</term>
<term>Antirétroviraux (administration et posologie)</term>
<term>Antirétroviraux (usage thérapeutique)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Association de médicaments</term>
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Inhibiteurs de protéases (administration et posologie)</term>
<term>Inhibiteurs de protéases (pharmacologie)</term>
<term>Inhibiteurs de protéases (usage thérapeutique)</term>
<term>Lopinavir</term>
<term>Protéines de fusion virale (antagonistes et inhibiteurs)</term>
<term>Pyrimidinones (administration et posologie)</term>
<term>Pyrimidinones (pharmacologie)</term>
<term>Pyrimidinones (usage thérapeutique)</term>
<term>Ribavirine (administration et posologie)</term>
<term>Ribavirine (usage thérapeutique)</term>
<term>Ritonavir (administration et posologie)</term>
<term>Ritonavir (pharmacologie)</term>
<term>Ritonavir (usage thérapeutique)</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Virus du SRAS ()</term>
<term>Études de cohortes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Anti-Retroviral Agents</term>
<term>Antiviral Agents</term>
<term>Protease Inhibitors</term>
<term>Pyrimidinones</term>
<term>Ribavirin</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Viral Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Protease Inhibitors</term>
<term>Pyrimidinones</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-HIV Agents</term>
<term>Anti-Retroviral Agents</term>
<term>Antiviral Agents</term>
<term>Protease Inhibitors</term>
<term>Pyrimidinones</term>
<term>Ribavirin</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Antirétroviraux</term>
<term>Antiviraux</term>
<term>Inhibiteurs de protéases</term>
<term>Pyrimidinones</term>
<term>Ribavirine</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Protéines de fusion virale</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>HIV Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Inhibiteurs de protéases</term>
<term>Pyrimidinones</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à VIH</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Agents antiVIH</term>
<term>Antirétroviraux</term>
<term>Antiviraux</term>
<term>Inhibiteurs de protéases</term>
<term>Pyrimidinones</term>
<term>Ribavirine</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Clinical Trials as Topic</term>
<term>Cohort Studies</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Lopinavir</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Association de médicaments</term>
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Lopinavir</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
<term>Études de cohortes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Inhibition of viral assembly (protease inhibitors) and of fusion of viral and target membranes (fusion inhibitors) are general approaches to antiviral treatment, not specific for HIV. Nonetheless, the agents that induce these phenomena are most often specific for a given virus or virus family. Drugs developed for HIV treatment were reevaluated for use against severe acute respiratory syndrome-coronavirus (SARS-CoV) during and after the epidemic in 2003, in view of the absence of any other available treatment. Of the protease and entry inhibitors approved for treating HIV-infected patients, none was effective against SARS-CoV, although in vitro activity against this virus was reported for the protease inhibitor lopinavir/ritonavir, in results that have not been confirmed in the most recent studies. The epidemiologic methods used to assess this drug's efficacy are not robust. Preliminary results for SARS treatment with protease and entry inhibitors, although at early stages of development, are promising.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Guery, Benoit" sort="Guery, Benoit" uniqKey="Guery B" first="Benoît" last="Guéry">Benoît Guéry</name>
<name sortKey="Yazdanpanah, Yazdan" sort="Yazdanpanah, Yazdan" uniqKey="Yazdanpanah Y" first="Yazdan" last="Yazdanpanah">Yazdan Yazdanpanah</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C26 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003C26 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16462674
   |texte=   [Antiretroviral drugs in severe acute respiratory syndrome].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16462674" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021